Jennifer Martin

Adapting to market shifts, elevating compliance, and strengthening connections across the industry

Maybe it's the pace of change across the auto finance industry. Maybe it's the growing complexity of the regulatory environment. Or maybe it's the fact that the NAF Association Annual Conference is celebrating a major milestone.

Monoclonal antibodies (Mabs) have become key drugs in cancer treatment, either as targeted therapies or more recently as immune checkpoint inhibitors (ICIs). The fact that only some patients benefit from these drugs poses the usual question in the field of onco‐hematology: that of the benefit of individual dosing and the potential of therapeutic drug monitoring (TDM) to carry out this individualization. However, Mabs present unique pharmacological characteristics for TDM, and the pharmacokinetic–pharmacodynamic relationship observed should be interpreted differently than that observed for conventional drugs and small molecules. This pharmacology practice review has been summarized from a public debate between the authors at the International TDM and Clinical Toxicology meeting in Banff, 2020, regarding the potential roles of TDM in the Mab/ICI setting.

Abstract Decentralised clinical trials (DCTs) may help address underrepresentation in digital mental health research, but their effectiveness in reaching underserved populations is unclear.

Frederick County officials are racing toward an October 1 state deadline to decide how to spend roughly $3 million in cannabis tax revenue and